vs
i3 Verticals, Inc.（IIIV）与RHYTHM PHARMACEUTICALS, INC.（RYTM）财务数据对比。点击上方公司名可切换其他公司
RHYTHM PHARMACEUTICALS, INC.的季度营收约是i3 Verticals, Inc.的1.1倍（$60.1M vs $52.7M），i3 Verticals, Inc.净利率更高（0.9% vs -92.6%，领先93.5%），RHYTHM PHARMACEUTICALS, INC.同比增速更快（83.8% vs -14.6%），过去两年RHYTHM PHARMACEUTICALS, INC.的营收复合增速更高（43.8% vs -4.7%）
Prusa i3是捷克Prusa Research公司生产的熔融沉积成型3D打印机系列，以Original Prusa i3为注册商标推出，同时也是RepRap项目的组成部分。2016年该系列就被评为全球使用率最高的3D打印机，最早由Josef Průša在2012年完成设计，2015年正式推出商用套件版本，目前最新型号同时提供散件套件和原厂组装版本，具备性价比高、易操作的优势。
Rhythm Pharmaceuticals是一家专注于罕见病领域的生物制药企业，主要开发和商业化针对罕见遗传性肥胖症的靶向疗法，覆盖POMC缺陷、LEPR缺陷、巴德-毕德氏综合征等适应症，服务北美、欧洲地区缺少有效治疗方案的患者群体。
IIIV vs RYTM — 直观对比
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $52.7M | $60.1M |
| 净利润 | $484.0K | $-55.6M |
| 毛利率 | — | 88.1% |
| 营业利润率 | 3.1% | -87.1% |
| 净利率 | 0.9% | -92.6% |
| 营收同比 | -14.6% | 83.8% |
| 净利润同比 | -76.5% | — |
| 每股收益（稀释后） | $0.02 | $-0.83 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q1 26 | — | $60.1M | ||
| Q4 25 | $52.7M | $57.3M | ||
| Q3 25 | $46.0M | $51.3M | ||
| Q2 25 | $51.9M | $48.5M | ||
| Q1 25 | $63.1M | $32.7M | ||
| Q4 24 | $52.2M | $41.8M | ||
| Q3 24 | $32.0M | $33.3M | ||
| Q2 24 | $46.2M | $29.1M |
| Q1 26 | — | $-55.6M | ||
| Q4 25 | $484.0K | $-47.5M | ||
| Q3 25 | $3.1M | $-52.9M | ||
| Q2 25 | $12.9M | $-46.6M | ||
| Q1 25 | $-154.0K | $-49.5M | ||
| Q4 24 | $2.1M | $-43.3M | ||
| Q3 24 | $117.9M | $-43.6M | ||
| Q2 24 | $-7.5M | $-32.3M |
| Q1 26 | — | 88.1% | ||
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 89.9% |
| Q1 26 | — | -87.1% | ||
| Q4 25 | 3.1% | -82.2% | ||
| Q3 25 | 3.2% | -102.6% | ||
| Q2 25 | -9.3% | -93.4% | ||
| Q1 25 | 8.0% | -143.7% | ||
| Q4 24 | 3.9% | -98.6% | ||
| Q3 24 | 10.6% | -132.0% | ||
| Q2 24 | -2.8% | -139.2% |
| Q1 26 | — | -92.6% | ||
| Q4 25 | 0.9% | -83.0% | ||
| Q3 25 | 6.7% | -103.1% | ||
| Q2 25 | 24.8% | -96.1% | ||
| Q1 25 | -0.2% | -151.4% | ||
| Q4 24 | 3.9% | -103.6% | ||
| Q3 24 | 368.2% | -131.2% | ||
| Q2 24 | -16.3% | -110.9% |
| Q1 26 | — | $-0.83 | ||
| Q4 25 | $0.02 | $-0.73 | ||
| Q3 25 | $0.14 | $-0.82 | ||
| Q2 25 | $0.50 | $-0.75 | ||
| Q1 25 | $0.00 | $-0.81 | ||
| Q4 24 | $0.08 | $-0.71 | ||
| Q3 24 | $4.93 | $-0.73 | ||
| Q2 24 | $-0.32 | $-0.55 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $37.5M | $340.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $358.5M | $122.9M |
| 总资产 | $595.9M | $442.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q1 26 | — | $340.6M | ||
| Q4 25 | $37.5M | $388.9M | ||
| Q3 25 | $66.7M | $416.1M | ||
| Q2 25 | $55.5M | $291.0M | ||
| Q1 25 | $7.7M | $314.5M | ||
| Q4 24 | $85.6M | $320.6M | ||
| Q3 24 | $86.5M | $298.4M | ||
| Q2 24 | $9.7M | $319.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $0 | — | ||
| Q2 25 | $0 | — | ||
| Q1 25 | $12.0M | — | ||
| Q4 24 | $26.2M | — | ||
| Q3 24 | $26.2M | — | ||
| Q2 24 | $374.1M | — |
| Q1 26 | — | $122.9M | ||
| Q4 25 | $358.5M | $139.1M | ||
| Q3 25 | $389.6M | $148.8M | ||
| Q2 25 | $383.3M | $-11.9M | ||
| Q1 25 | $385.2M | $18.9M | ||
| Q4 24 | $375.0M | $21.7M | ||
| Q3 24 | $379.7M | $11.2M | ||
| Q2 24 | $249.7M | $39.3M |
| Q1 26 | — | $442.3M | ||
| Q4 25 | $595.9M | $480.2M | ||
| Q3 25 | $638.4M | $506.9M | ||
| Q2 25 | $623.3M | $372.7M | ||
| Q1 25 | $646.4M | $386.7M | ||
| Q4 24 | $726.2M | $392.3M | ||
| Q3 24 | $730.7M | $363.6M | ||
| Q2 24 | $861.7M | $381.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.03× | — | ||
| Q4 24 | 0.07× | — | ||
| Q3 24 | 0.07× | — | ||
| Q2 24 | 1.50× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.1M | — |
| 自由现金流经营现金流 - 资本支出 | $13.8M | — |
| 自由现金流率自由现金流/营收 | 26.2% | — |
| 资本支出强度资本支出/营收 | 0.6% | — |
| 现金转化率经营现金流/净利润 | 29.18× | — |
| 过去12个月自由现金流最近4个季度 | $6.5M | — |
8季度趋势，按日历期对齐
| Q1 26 | — | — | ||
| Q4 25 | $14.1M | $-25.4M | ||
| Q3 25 | $14.0M | $-26.6M | ||
| Q2 25 | $7.4M | $-23.3M | ||
| Q1 25 | $-27.1M | $-40.4M | ||
| Q4 24 | $11.5M | $-18.8M | ||
| Q3 24 | $15.1M | $-25.2M | ||
| Q2 24 | $8.1M | $-29.1M |
| Q1 26 | — | — | ||
| Q4 25 | $13.8M | — | ||
| Q3 25 | $13.5M | — | ||
| Q2 25 | $6.8M | — | ||
| Q1 25 | $-27.6M | — | ||
| Q4 24 | $11.0M | — | ||
| Q3 24 | $14.6M | — | ||
| Q2 24 | $7.2M | — |
| Q1 26 | — | — | ||
| Q4 25 | 26.2% | — | ||
| Q3 25 | 29.5% | — | ||
| Q2 25 | 13.1% | — | ||
| Q1 25 | -43.8% | — | ||
| Q4 24 | 21.1% | — | ||
| Q3 24 | 45.6% | — | ||
| Q2 24 | 15.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.6% | — | ||
| Q3 25 | 0.9% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | 0.8% | — | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | 1.9% | — |
| Q1 26 | — | — | ||
| Q4 25 | 29.18× | — | ||
| Q3 25 | 4.52× | — | ||
| Q2 25 | 0.57× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 5.59× | — | ||
| Q3 24 | 0.13× | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IIIV
| License And Service | $35.7M | 68% |
| Proprietary Payments Revenue | $14.5M | 27% |
| Other Revenue | $2.5M | 5% |
RYTM
暂无分部数据
